Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells

International Archives of Allergy and Immunology

Volumn 140, Issue SUPPL. 1, 2006, Pages 8-16

  Itakura, Atsuko ^a   Kikuchi, Yuji ^b   Kouro, Taku ^a   Ikutani, Masashi ^a   Takaki, Satoshi ^a   Askenase, Philip W ^c   Takatsu, Kiyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B 1 cell; Contact sensitivity; Eosinophils; Interleukin 5

Indexed keywords

ANTIGEN; EOSINOPHIL PEROXIDASE; HAPTEN; IMMUNOGLOBULIN M; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 5 RECEPTOR ALPHA; OXAZOLONE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; B LYMPHOCYTE ACTIVATION; CELL INFILTRATION; CONFERENCE PAPER; CONTACT SENSITIVITY; CONTROLLED STUDY; EAR EDEMA; EDEMA; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SKIN; SKIN SENSITIZATION; SPECIES COMPARISON; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TISSUE SECTION;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTE SUBSETS; DERMATITIS, CONTACT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL PEROXIDASE; EOSINOPHILS; FEMALE; HAPTENS; IMMUNOGLOBULIN M; INTERLEUKIN-5; MALE; MICE; MICE, KNOCKOUT; OXAZOLONE; SPLEEN;

EID: 33745096612     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092705     Document Type: Conference Paper

References (28)

1. Askenase PW: Delayed-type hypersensitivity and cellular immunity: effector/regulator molecules and mechanisms; in Adkinson NFJ, Holgate ST, Bochner BS, Busse WW, Yunginger JW, Simmons EER (eds): Middleton's Allergy: Principles and Practice. St. Louis, Mosby, 2003, pp 425-451.
2. Marchal G, Seman M, Milon G, Truffa-Bachi P, Zilberfarb V: Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 1982;129:954-958.
3. Roupe G, Ridell B: The cellular infiltrate in contact hypersensitivity to picryl chloride in the mouse. Acta Derm Venereol 1979;59:191-195.
4. Tsuji RF, Szczepanik M, Kawikova I, Paliwal V, Campos RA, Itakura A, Akahira-Azuma M, Baumgarth N, Herzenberg LA, Askenase PW: B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002;196:1277-1290.
5. Hardy RR, Hayakawa K: CD5 B cells, a fetal B cell lineage. Adv Immunol 1994;55:297-339.
6. Itakura A, Szczepanik M, Campos RA, Paliwal V, Majewska M, Matsuda H, Takatsu K, Askenase PW: An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J Immunol 2005;175:7170-7178.
7. Hitoshi Y, Yamaguchi N, Korenaga M, Mita S, Tominaga A, Takatsu K: In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice. Int Immunol 1991;3:135-139.
8. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA: Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-224.
9. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
10. Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, Kanazawa H, Sunaga S, Kinashi T, Yoshimura K, Miyazaki J, Takaki S, Takatsu K: Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 1996;4:483-494.
11. Moon BG, Takaki S, Miyake K, Takatsu K: The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol 2004;172:6020-6029.
12. Fong TA, Mosmann TR: The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 1989;143:2887-2893.
13. Xu H, Dilulio NA, Fairchild RL: T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1001-1012.
14. Biedermann T, Mailhammer R, Mai A, Sander C, Ogilvie A, Brombacher F, Maier K, Levine AD, Rocken M: Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur J Immunol 2001;31:1582-1591.
15. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D: Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995;182:99-108.
16. Campos RA, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M, Askenase PW: Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003;198:1785-1796.
17. Akahira-Azuma M, Szczepanik M, Tsuji RF, Campos RA, Itakura A, Mobini N, McNiff J, Kawikova I, Lu B, Gerard C, Pober JS, Askenase PW: Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines. Immunology 2004;111:306-317.
18. Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB: Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 2004;16:685-695.
19. Askenase PW, Asherson GL: Contact sensitivity to oxazolone in the mouse. 8. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay. Immunology 1972;23:289-298.
20. Nagai H, Ueda Y, Tanaka H, Hirano Y, Nakamura N, Inagaki N, Takatsu K, Kawada K: Effect of overproduction of interleukin 5 on dinitrofluorobenzene- induced allergic cutaneous response in mice. J Pharmacol Exp Ther 1999;288:43-50.
21. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-1742.
22. Iwamoto I, Tomoe S, Tomioka H, Takatsu K, Yoshida S: Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J Leukoc Biol 1992;52:572-578.
23. Van Loveren H, Askenase PW: Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol 1984;133:2397-2401.
24. Tsicopoulos A, Hamid Q, Haczku A, Jacobson MR, Durham SR, North J, Barkans J, Corrigan CJ, Meng Q, Moqbel R, et al: Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994;94:764-772.
25. Matsumoto N, Katoh S, Mukae H, Matsuo T, Takatsu K, Matsukura S: Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation. Int Arch Allergy Immunol 2003;130:209-215.
26. Kagami S, Nakajima H, Kumano K, Suzuki K, Suto A, Imada K, Davey HW, Saito Y, Takatsu K, Leonard WJ, Iwamoto I: Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 2000;95:1370-1377.
27. Tanaka Y, Delaporte E, Dubucquoi S, Gounni AS, Porchet E, Capron A, Capron M: Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994;103:589-592.
28. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL: IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004;114:427-437.